Deph Labs is a health technology company pioneering the future of personalised and preventative medicine. Through cutting-edge epigenetics, AI, and precision health science, Deph Labs is building the next generation of consumer healthcare brands, including UMMU, the world’s first female-first DNA and epigenetic platform, and ENGNE, a precision health platform helping people optimise performance, longevity, and wellbeing through advanced biological insights.